AERIE PHARMACEUTICALS INC - COM (AERI)

CUSIP: 00771V108

Q1 2018 13F Holders as of 31 Mar 2018

Share change
+4,675,677
Put/Call ratio
144%
SEC-reported price per share
$54.25
Number of holders
168
Value change
+$249,794,827
Number of buys
84
Open additional details 1 more signal available
Number of sells
73

Security key

00771V108

Report period

Q1 2018

Institutions

168

Top holders

10

Ownership snapshot

Top reported holders of AERI - AERIE PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
168
Shares
42,933,190
Rows available
168
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
174
Q1 2018 holders
168
Holder diff
-6
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 value Q1 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .